BIOLASE INC

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch BIOLASE INC and buy or sell other stocks, ETFs, and their options commission-free!

About BIOLQ

BIOLASE, Inc. is a medical device company, which engages in the developing, manufacturing, marketing and sale of laser systems in dentistry and medicine. It operates through the Waterlase (all-tissue) systems, and Diode (soft-tissue) systems products. 

CEO
Gwang-Bum Park
CEOGwang-Bum Park
Employees
157
Employees157
Headquarters
Lake Forest, California
HeadquartersLake Forest, California
Founded
1984
Founded1984
Employees
157
Employees157

BIOLQ Key Statistics

Market cap
3.66K
Market cap3.66K
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
0.90
Average volume0.90
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$0.0139
52 Week high$0.0139
52 Week low
$0.00
52 Week low$0.00

Stock Snapshot

As of today, BIOLASE INC(BIOLQ) shares are valued at $0.00. The company's market cap stands at 3.66K.

During the trading day, BIOLASE INC(BIOLQ) stock saw an opening price of —, a peak of —, and a bottom of —.

Trading volume for BIOLASE INC(BIOLQ) stock has reached 0, versus its average volume of 0.9.

Over the past 52 weeks, BIOLASE INC(BIOLQ) stock has traded between a high of $0.01 and a low of $0.00.

Over the past 52 weeks, BIOLASE INC(BIOLQ) stock has traded between a high of $0.01 and a low of $0.00.

People also own

Based on the portfolios of people who own BIOLQ. This list is generated using Robinhood data, and it’s not a recommendation.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.